Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Genetic Tests

Simple Test Predicts Childhood Cancer Relapse

High-risk neuroblastoma, which occurs mostly in children under five, is treated with surgery and chemotherapy, and neuroblastomas currently rated low risk are just removed or left untreated while doctors 'wait and see', but a fraction of low risk tumors recur and ultimately kill. More...
26 May 2016

Genetic Test Predicts Adverse Reaction To Toxic Goiter Treatment

Agranulocytosis is an acute condition involving a severe and dangerous leukopenia or lowered white blood cell count and drug-induced agranulocytosis is a potentially life-threatening adverse reaction, and adverse drugs reactions are a leading cause of admission to hospital. More...
26 May 2016

Blood Marker Determines Response To Colorectal Cancer Drug

A marker has been identified that shows up in a blood test that determines which patients with colorectal cancer that has metastasized would benefit from receiving the drug cetuximab. More...
26 May 2016

New Gene Associated With Familial High Cholesterol

The gene that explains one quarter of all familial hypercholesterolemia with very high blood cholesterol has been revealed. Familial hypercholesterolemia is the most common genetic disorder leading to premature death, found in 1 in 200 people. More...
26 May 2016

Dengue Rapid Diagnostic Tests Recycled For Serotyping

Dengue virus infection causes major public health problems in tropical and subtropical areas, but in many endemic areas, inadequate access to laboratory facilities is a major obstacle to surveillance and study of dengue epidemiology. More...
25 May 2016

Norovirus Assays Compared In Acute Gastroenteritis Patients

Noroviruses (NoVs) are the most common cause of acute viral gastroenteritis worldwide and they affect all age group and are frequently involved in outbreaks in communal facilities, such as hospitals, schools, prisons, cruise ships. More...
24 May 2016
Image: The BioMek FXP automation workstation (Photo courtesy of Beckman Coulter).

Innovative Gene Testing Technology Finds Cancer Risks

A new method has been developed for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed. More...
19 May 2016


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2016 Globetech Media. All rights reserved.